TRAF2 and atherosclerosis: Only one study has tested the impact of TRAF2 in experimental atherosclerosis with TRAF+/− mice in bone marrow transplantations using TRAF2-deficient hematopoietic cells from fetal livers to generate viable mice with a deficiency of TRAF2 in hematopoietic cells (103).